![]() Endo Pharmaceuticals’ specialty portfolio includes products for urology, men’s health, orthopedics and endocrinology. Eagle Pharmaceuticals (EGRX) announces that Par Pharmaceutical has unilaterally withdrawn its bid to block the launch of the company’s recently approved generic alternative to. develops and markets high-value, quality branded pharmaceutical products for patients in need. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |